June 27, 2017
Makoto Nakamura, VP, Oncology, Pfizer Japan Pfizer Japan ramped up its oncology sales reps by around 20% this month, reorganizing them into two groups each focusing on blood and solid cancers, as it preps for the rollout of the breast...read more